Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in the transaction.Leap Therapeutics, Inc. (Nasdaq:LPTX) has entered into a securities purchase agreement with a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
